{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:03:36Z","timestamp":1790870616137,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1023\/a:1006447325077","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:03:28Z","timestamp":1040522608000},"page":"21-32","source":"Crossref","is-referenced-by-count":20,"title":["Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography"],"prefix":"10.1007","volume":"61","author":[{"given":"Jean Louis","family":"Alb\u00e9rini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Denzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Devillers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Tass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Dazord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry Le","family":"Simple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Laissue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf de","family":"Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Le","family":"Cloirec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claudei","family":"Reubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bourguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"264042_CR1","first-page":"1551","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551\u20131557, 1983","journal-title":"An NSABP update. Cancer"},{"key":"264042_CR2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/bjs.1800730723","volume":"73","author":"MW Kissin","year":"1986","unstructured":"Kissin MW, Querci della Rovere G, Easton D, Westbuy G: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73: 580\u2013584, 1986","journal-title":"Br J Surg"},{"key":"264042_CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/bjs.1800790326","volume":"79","author":"AL Hoe","year":"1992","unstructured":"Hoe AL, Iven D, Royle GT, Taylor I: Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 79: 261\u2013262, 1992","journal-title":"Br J Surg"},{"key":"264042_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jcla.1860030302","volume":"3","author":"M Fekete","year":"1989","unstructured":"Fekete M, Wittiliff JL, Schally AV: Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormonereleasing hormone, somatostatin, epidemal growth factor, and sex steroids in 500 biopsy samples of human breast cancer. Clin Lab Anal 3: 137\u2013147, 1989","journal-title":"Clin Lab Anal"},{"key":"264042_CR5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ijc.2910460315","volume":"46","author":"JC Reubi","year":"1990","unstructured":"Reubi JC, Waser B, Foekens JA, Klijn JGM, Lamberts SWJ, Laissue J: Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF-receptors. Int J Cancer 46: 416\u2013420, 1990","journal-title":"Int J Cancer"},{"key":"264042_CR6","first-page":"5969","volume":"50","author":"JC Reubi","year":"1990","unstructured":"Reubi JC, Kvols LK, Waser B, et al.: Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 50: 5969\u20135977, 1990","journal-title":"Cancer Res"},{"key":"264042_CR7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0016-5085(94)90754-4","volume":"106","author":"JC Reubi","year":"1994","unstructured":"Reubi JC, Mazzucchelli L, Laissue J: Intestinal vessels express a high density of somatostatin receptors in human in-flammatory bowel disease. Gastroenterology 106: 951\u2013959, 1994","journal-title":"Gastroenterology"},{"key":"264042_CR8","first-page":"2974","volume":"80","author":"S Viki-Topic","year":"1995","unstructured":"Viki-Topic S, Raisch KP, Kvols LK, Vuk-Pavlovic L: Expression of somatostain receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma. J Clin Endocrinol Metab 80: 2974\u20132979, 1995","journal-title":"J Clin Endocrinol Metab"},{"key":"264042_CR9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/1097-0142(19890915)64:6<1254::AID-CNCR2820640615>3.0.CO;2-D","volume":"64","author":"JC Reubi","year":"1989","unstructured":"Reubi JC, Torhorst J: The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer. Cancer 64: 1254\u20131260, 1989","journal-title":"Cancer"},{"key":"264042_CR10","first-page":"622","volume":"37","author":"M Bajc","year":"1996","unstructured":"Bajc M, Ingvar C, Palmer J: Dynamic Indium-111-pentetreotide scintigraphy in breast cancer. J Nucl Med 37: 622\u2013626, 1996","journal-title":"J Nucl Med"},{"key":"264042_CR11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(94)92637-9","volume":"343","author":"CHJ Van Eijck","year":"1994","unstructured":"Van Eijck CHJ, Krenning EP, Bootsma A, et al.: Somatostatin receptor scintigraphy in primary breast cancer. Lancet 343: 640\u2013644, 1994","journal-title":"Lancet"},{"key":"264042_CR12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WH, et al.: Somatostatin receptor scintigraphy with [Indium-111-DTPA-DPhe-1] and [iodine-123-Tyr-3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20: 716\u2013731, 1993","journal-title":"Eur J Nucl Med"},{"key":"264042_CR13","first-page":"7002","volume":"49","author":"JA Foekens","year":"1989","unstructured":"Foekens JA, Portengen H, van Putten WLJ, et al.: Prognostic value of receptors for insulin-like growth factor 1, somatostatin and epidermic growth factor in human breast cancer. Cancer Res 49: 7002\u20137009, 1989","journal-title":"Cancer Res"},{"key":"264042_CR14","first-page":"312","volume":"24","author":"G Vural","year":"1997","unstructured":"Vural G, Atasever MUT, Ozur I, Ozdemir A, Gokcora N: Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: preliminary results. Eur J Nucl Med 24: 312\u2013315, 1997","journal-title":"Eur J Nucl Med"},{"key":"264042_CR15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/BF02439552","volume":"24","author":"A Chiti","year":"1997","unstructured":"Chiti A, Agresti R, Maffioli LS, et al.: Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography. Eur J Nucl Med 24: 192\u2013196, 1997","journal-title":"Eur J Nucl Med"},{"key":"264042_CR16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/BF00800591","volume":"22","author":"M Cimitan","year":"1995","unstructured":"Cimitan M, Volpe R, Candiani E, et al.: The use of thallium-201 in the preoperative detection of breast cancer: an adjuct to mammography and ultrasonography. Eur J Nucl Med 22: 1110\u20131117, 1995","journal-title":"Eur J Nucl Med"},{"key":"264042_CR17","first-page":"2095","volume":"34","author":"VW Lee","year":"1993","unstructured":"Lee VW, Sax EJ, McAneny DB, et al.: A complementary role for thallium-201 scintigraphy with manmmography in the diagnosis of breast cancer. J Nucl Med 34: 2095\u20132100, 1993","journal-title":"J Nucl Med"},{"key":"264042_CR18","first-page":"18","volume":"34","author":"AD Waxman","year":"1993","unstructured":"Waxman AD, Ramanna L, Memsic LD, et al.: Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 34: 18\u201323, 1993","journal-title":"J Nucl Med"},{"key":"264042_CR19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00006231-199408000-00005","volume":"15","author":"Z Burak","year":"1994","unstructured":"Burak Z, Argon M, Memis A, et al.: Evaluation of palpable breast masses with 99mTc-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Comm 15: 604\u2013612, 1994","journal-title":"Nucl Med Comm"},{"key":"264042_CR20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00003072-199212000-00006","volume":"12","author":"RJ Campeau","year":"1992","unstructured":"Campeau RJ, Kronemer KA, Sutherland CM: Concordant uptake of Tc\u201399m sestamibi and T1-201 in unsuspected breast tumor. Clin Nucl Med 12: 936\u2013937, 1992","journal-title":"Clin Nucl Med"},{"key":"264042_CR21","first-page":"432","volume":"21","author":"CH Kao","year":"1994","unstructured":"Kao CH, Wang SJ, Liu TJ: The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: 432\u2013436, 1994","journal-title":"Eur J Nucl Med"},{"key":"264042_CR22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1148\/radiology.196.2.7617855","volume":"196","author":"I Khalkhali","year":"1995","unstructured":"Khalkhali I, Cutrone JA, Mena I, et al.: Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 196: 421\u2013426, 1995","journal-title":"Radiology"},{"key":"264042_CR23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/BF00238124","volume":"21","author":"F Scopinaro","year":"1994","unstructured":"Scopinaro F, Schillaci O, Scarpini M, et al.: Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 21: 984\u2013987, 1994","journal-title":"Eur J Nucl Med"},{"key":"264042_CR24","first-page":"1766","volume":"36","author":"F Dehdashti","year":"1995","unstructured":"Dehdashti F, Mortimer JE, Siegel BA, et al.: Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro assays. J Nucl Med 36: 1766\u20131774, 1995","journal-title":"J Nucl Med"},{"key":"264042_CR25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.187.3.8497624","volume":"187","author":"LP Adler","year":"1993","unstructured":"Adler LP, Crowe JP, Al-Kaisi NK, Sunshine JL: Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology 187: 743\u2013750, 1993","journal-title":"Radiology"},{"key":"264042_CR26","first-page":"1097","volume":"13","author":"K Kubota","year":"1989","unstructured":"Kubota K, Matsuzawa T, Amemiya A, Kondo M, Fujiwara T, Watanuki S: Imaging of breast cancer with [18F]fluorodexyglucose and positron emission tomography. J Comput Assist Tomogr 13: 1097\u20131098, 1989","journal-title":"J Comput Assist Tomogr"},{"key":"264042_CR27","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1002\/1097-0142(19930615)71:12<3920::AID-CNCR2820711220>3.0.CO;2-N","volume":"71","author":"OE Nieweg","year":"1993","unstructured":"Nieweg OE, Kim EE, Wong WH, et al.: Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 71: 3920\u20133925, 1993","journal-title":"Cancer"},{"key":"264042_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000658-199207000-00005","volume":"216","author":"NY Tse","year":"1992","unstructured":"Tse NY, Hoh C, Hawkins RA, et al.: The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg 216: 27\u201334, 1992","journal-title":"Ann Surg"},{"key":"264042_CR29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1148\/radiology.179.3.2027989","volume":"179","author":"RL Wahl","year":"1991","unstructured":"Wahl RL, Cody RL, Hutchins GD, MudgeTT EE: Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 179: 765\u2013770, 1991","journal-title":"Radiology"},{"key":"264042_CR30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00702620","volume":"15","author":"H Minn","year":"1989","unstructured":"Minn H, Soini I: [18F]Fluorodeoxyglucose scintigraphy in diagnosis and follow-up of treatment in advanced breast cancer. Eur J Nucl Med 15: 61\u201366, 1989","journal-title":"Eur J Nucl Med"},{"key":"264042_CR31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/bjc.1993.143","volume":"67","author":"R Huovinen","year":"1993","unstructured":"Huovinen R, Leskinen-Kallio S, Nagren K, Lehikoinen P, Ruotsalainen U, Ter\u00e4s M: Carbon-11-methionine and PET in evaluation of treatment response of breast cancer. Br J Cancer 67: 787\u2013791, 1993","journal-title":"Br J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006447325077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006447325077\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006447325077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006447325077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:22:32Z","timestamp":1750479752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006447325077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["264042"],"URL":"https:\/\/doi.org\/10.1023\/a:1006447325077","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}